Why is "Bladder cancer" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-10 22:44:09
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
Bladder cancer is the abnormal growth of cells in the bladder. These cells can grow to form a tumor, which eventually spreads, damaging the bladder and other organs. Most people with bladder cancer are diagnosed after noticing blood in their urine. Those suspected of having bladder cancer typically have their bladder inspected by a thin medical camera, a procedure called cystoscopy. Suspected tumors are removed and examined to determine if they are cancerous. Based on how far the tumor has spread, the cancer case is assigned a stage 0 to 4; a higher stage indicates a more widespread and dangerous disease.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Bladder Cancer: Urine Test Improves Relapse Predictions - Inside Precision Medicine
-
A urine test that could change the course of bladder cancer care - Medical Xpress
-
Managing Radiation Toxicity After Trimodal Therapy for Bladder Cancer - Antoine Van Der Heijden & Neha Vapiwala - UroToday
-
ctDNA Testing Is Poised to Reshape Risk Assessment and Treatment Decision-Making in Bladder Cancer - OncLive
-
IU researchers play role in development of new bladder cancer treatment - Indianapolis Business Journal
-
Doctors Say This Is the Number-1 Sign of Bladder Cancer - Prevention
-
Clinical Practice Updates: Navigating the New Standard of Care in Bladder Cancer - Oncology Nursing News
-
Yale Launches Innovative Clinical Trial for Metastatic Bladder Cancer - Yale School of Medicine
-
Blood Test Predicts Which Bladder Cancer Patients May Safely Skip Surgery - Fox Chase Cancer Center
-
Study finds link between colorblindness and death from bladder cancer - Stanford Medicine
-
Colour blindness as a risk factor for bladder cancer - Nature
-
Perioperative outcomes following open radical cystectomy in the setting of locally advanced bladder cancer - springermedicine.com
-
Urine DNA test predicts bladder cancer recurrence and guides BCG therapy - Labmate Online
-
New Gene Therapy Nears EU Nod for Bladder Cancer - Medscape
-
USC study suggests type 1 diabetes may significantly raise bladder cancer risk - Keck School of Medicine of USC
-
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer - NEJM
-
New Survey Reveals Non-Muscle Invasive Bladder Cancer Patients Seek More Care Conversations - ImmunityBio
-
Can ctDNA Predict Metastatic Risk in Bladder Cancer? - Oncology News Central
-
Non-Invasive Urine Test Improves Prediction of Bladder Cancer Treatment Outcomes: Study - Medical Dialogues
-
A multi-modal approach for decision making in bladder cancer - Nature
-
New drug developed at UC Davis offers hope to bladder cancer patients - University of California - Davis Health
-
Can ctDNA Negativity Predict Metastasis-Free Survival in Muscle-Invasive Bladder Cancer? - The ASCO Post
-
Mayo Clinic expert highlights improved survival in muscle-invasive bladder cancer and kidney cancer - Mayo Clinic News Network
-
Cystectomy Matches Bladder Sparing for Function in Bladder Cancer, Study Finds - Oncology News Central
-
Technology originating at MIT leads to approved bladder cancer treatment - MIT News
-
Top 10 Urology Times bladder cancer articles of 2025 - Urology Times
-
Non-Chemo, Biomarker-Driven Perioperative Strategies Highlight Bladder Cancer Presentations to Watch at ASCO GU 2026 - OncLive
-
Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapies - Nature
-
HER2 in Bladder Cancer: A Frequent but Complex and Dynamic Biomarker - Daniele Raggi - UroToday
-
Hypoxia-inducible factor 1α exerts dual roles in bladder cancer progression through TIMP3-mediated regulation of angiogenesis and invasion | Scientific Reports - Nature
-
Bladder Cancer: What You Need to Know - University of Colorado Anschutz
-
MET signaling drives acquired resistance to erdafitinib in muscle-invasive bladder cancer cells - Nature
-
New drug developed at UC Davis offers hope to bladder cancer patients - University of California - Davis Health
-
New Drug-Releasing System Eliminates Bladder Cancer in Over 80 of Patients in a Phase II Trial - The ASCO Post
-
Neoadjuvant Sacituzumab Govitecan Plus Perioperative Pembrolizumab in Muscle-Invasive Bladder Cancer - The ASCO Post
-
New treatment reduces recurrence and improves survival in bladder cancer - Karolinska Institutet
-
Groundbreaking Advances for Patients with Muscle-Invasive Bladder Cancer and More to Come - Memorial Sloan Kettering Cancer Center
-
MD Anderson helps bladder cancer survivor through recurrences - UT MD Anderson
-
Tiny implant wipes out bladder cancer in 82% of patients - ScienceDaily
-
Bladder Cancer Therapy Enfortumab Vedotin (Padcev) Approved by FDA for More Patients - Memorial Sloan Kettering Cancer Center
-
Exploring KDM6A as a Clinically Actionable Biomarker in Bladder Cancer - Sangeeta Goswami - UroToday
-
Gemcitabine Intravesical System May Transform Bladder Cancer Treatment - CancerNetwork
-
New Approach May Reduce Recurrence in Muscle-Invasive Bladder Cancer - Cure Today
-
Can KDM6A Mutations Help Guide Treatment Selection in Bladder Cancer? - The ASCO Post
-
Muscle-Invasive Bladder Cancer Guideline Update Released by EAU - Renal and Urology News
-
New pathway explains poor response to bladder cancer immunotherapy - News-Medical
-
Bladder Cancer Symptoms and What You Need to Know About Treatment - University of Rochester Medical Center
-
Can a New Testing Method Allow More Patients With Bladder Cancer to Avoid Radical Cystectomy - The ASCO Post
-
Oncological outcome and survival predictors of widowed patients with bladder cancer in special populations - Nature
-
New treatment eliminates bladder cancer in 82% of patients - Keck Medicine of USC
-
ImmunityBio responds to FDA scrutiny over Anktiva promotional claims with new protocols - Fierce Pharma
-
New Hope for Bladder Cancer Detection A Simple Urine Test - Johns Hopkins Medicine
-
Stage IV bladder cancer caregiver: Why I’ll support UT MD Anderson until the day I die - UT MD Anderson
-
Mountaineer Rob Mahedy Finds New Sense of Community Through Bladder Cancer Journey - University of Colorado Anschutz
-
Slow–release gemcitabine device targets bladder cancer more effectively - Oncology Central
-
Researchers develop urine test for bladder cancer - Stanford Medicine
-
Diabetes, Metformin, and Bladder Cancer Surgery - Johns Hopkins Medicine
-
Final Analysis Supports Use of Durvalumab Plus BCG Infusions in High-Risk Non–Muscle-Invasive Bladder Cancer - The ASCO Post
-
Despite ADC’s Withdrawal, TROP2 Targeting Still Has Potential in Bladder Cancer - Oncology News Central
-
Biomarker-Related Upheaval Ahead for Muscle-Invasive Bladder Cancer Care? - Oncology News Central
-
Bladder cancer clinical trial is region’s first - University of California - Davis Health
-
INSITE Study Aims to Pinpoint Bladder Cancer Patients Who Can Avoid Bladder Removal - Fox Chase Cancer Center
-
Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial - The Lancet
-
Category 1 Choices Available for Metastatic Bladder Cancer - Targeted Oncology
-
A Mentor, Innovator, and Leader in Bladder Cancer - University of Rochester Medical Center
-
What is intravesical therapy? Stamford Health offers innovative treatment for bladder cancer patients - Stamford Health
-
Biomarkers for Guiding Bladder Cancer Treatment Decisions - Andrea Necchi - UroToday
-
Recent Developments in Bacillus Calmette-Guérin-Unresponsive Non-muscle Invasive Bladder Cancer Research: The SunRISe 1 Study – Clinical Opinion - European Medical Journal
-
10 Ongoing Clinical Trials on Immunotherapy in Bladder Cancer - Oncodaily
-
Earlier ADC Use Raises Questions About Bladder Cancer Testing - Oncology News Central
-
Tumor-derived lactate fuels the STAT3-LCN2 pathway to promote bladder cancer malignancy and chemoresistance - Nature
-
WSAUA 2025: Treatment of Low Grade Intermediate Risk Non Muscle Invasive Bladder Cancer With UGN-102: Outcomes From the 5-year Long-Term Extension Study of the Single-Arm, Phase 2b Optima II Study - UroToday
-
First trial evidence supports minimal residual disease-guided adjuvant immunotherapy in bladder cancer - ESMO Daily Reporter
-
Bladder Cancer Remission Rate: What Patients Need to Know in 2025 - Oncodaily
-
TRIM29 promotes bladder cancer invasion by regulating the intermediate filament network and focal adhesion - Nature
-
Guidelines for High-Risk Non-Muscle Invasive Bladder Cancer Treatment Options - Neal Shore - UroToday
-
New approach after bladder cancer surgery reduces infections, complications and costs - Roswell Park Comprehensive Cancer Center
-
CU Surgeon Removes Bladder Cancer from Coach Prime - University of Colorado Anschutz
-
"Our goal is a solution for every bladder cancer patient" - Johnson & Johnson
-
Success Rate of Immunotherapy for Bladder Cancer. What Patients Need to Know in 2025 - Oncodaily
-
Robotic Surgery and Bladder Cancer: What You Need to Know | Huntsman Cancer Institute - University of Utah Health
-
Innovative Urine Test Poised to Transform Bladder Cancer Treatment - Bioengineer.org
-
Bladder Cancer in Dogs: Symptoms, Tests, Treatment, and Prevention - American Kennel Club
-
Peri-operative enfortumab vedotin plus pembrolizumab prolongs survival in muscle-invasive bladder cancer - ESMO Daily Reporter
-
Bladder cancer may be caused by the body’s response to a common virus, new research suggests - University of York
-
Colorado's Deion Sanders says he battled, beat bladder cancer - ESPN
-
FDA clears J&J’s drug-device combo for bladder cancer - BioPharma Dive
-
BCANTT 2025: Overcoming Immune Suppressive Myeloid Cell Barriers in Bladder Cancer - UroToday
-
Bladder cancer variants share aggressive features including a CA125+ cell state and targetable TM4SF1 expression - Nature
-
She leads the field of bladder cancer robotic surgery in North America, helping patients make the right call - UCHealth
-
SMH participates in global bladder cancer treatment clinical trial - Your Observer
-
New results suggest that bladder cancer could be caused by the body’s response to common childhood virus - Kidney Research UK
-
Seeing the unseen in bladder cancer surgery - News-Medical
-
Alan Davies reveals key symptom that led to bladder cancer diagnosis - The Independent
-
Bladder cancer treatment landscape is advancing, at last - statnews.com
-
Considerations for Treating Bladder Cancer in an Aging Patient Population - Tullika Garg - UroToday
-
Johnson & Johnson receives U.S. FDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancer - Johnson & Johnson
-
FDA Approves Gemcitabine Intravesical System for Non–Muscle-Invasive Bladder Cancer - The ASCO Post
-
U.S. FDA approval of INLEXZO™ (gemcitabine intravesical system) set to transform how certain bladder cancers are treated - Johnson & Johnson
-
AI in Bladder Cancer: Detection, Diagnosis, Predictions, Treatment - Oncodaily
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.